2M6.TI - Medtronic plc
| Previous close | 77.36 |
| Open | 83.00 |
| Bid | 78.00 x 0 |
| Ask | 78.04 x 0 |
| Day's range | 83.00 - 83.00 |
| 52-week range | 71.71 - 94.15 |
| Volume | |
| Avg. volume | 15 |
| Market cap | N/A |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | 21.87 |
| EPS (TTM) | 3.57 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireMedtronic names Ken Washington new Chief Technology and Innovation Officer
Medtronic plc (NYSE:MDT) today announced that Ken Washington, Ph.D., has been appointed Medtronic Chief Technology and Innovation Officer. In this newly created role, Dr. Washington will leverage his extensive experience leading technology development and execution across industries including robotics, consumer products, automotive, and space, to accelerate innovation-driven growth in service of the company's mission to alleviate pain, restore health and extend life. Dr. Washington will also bec
Motley Fool3 Reliable Dividend Growth Stocks to Buy Hand Over Fist in June
Adding these well-respected dividend payers to your portfolio could give you a stream of passive income that grows throughout your retirement years.
ZacksHere's Why You Should Retain Medtronic (MDT) Stock for Now
Investors continue to be optimistic about Medtronic (MDT) on the robust performances of the Neurosurgery and Cardiovascular portfolios.
Motley Fool2 Newly Minted AI Stocks to Buy Right Now
Nowhere is this trend more evident than in the recent parabolic growth of graphics, computing, and networking solutions company Nvidia (NASDAQ: NVDA). Thanks to its central role as a pillar of global AI architecture, Nvidia has seen its market cap swell to nearly $1 trillion in 2023.
Motley Fool2 Healthcare AI Stocks to Buy on the Dip
Artificial intelligence (AI) could change the way we treat and prevent illnesses, which makes it a highly valuable opportunity for companies. In fact, the global AI healthcare market is set to reach more than $100 billion later this decade, a Markets and Markets report shows. Two perfect examples are biotech Moderna (NASDAQ: MRNA) and medical device giant Medtronic (NYSE: MDT).
Motley FoolIs It Too Late to Buy Medtronic's Stock?
History has shown that purchasing stocks in resilient companies that can weather market highs and lows is an effective long-term investment strategy. Ireland-based Medtronic (NYSE: MDT), a major player in the medical device industry, is one such company. For years, the company steadily increased its revenue and earnings, keeping its business stable.
- PR Newswire
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual Goldman Sachs global healthcare conference on Monday, June 12, 2023.
ZacksMedtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Revised)
Medtronic (MDT) announces that the findings of the EV ICD Pivotal Study reinforce device safety and effectiveness.
Simply Wall St.Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69
Medtronic plc's ( NYSE:MDT ) periodic dividend will be increasing on the 14th of July to $0.69, with investors...
Motley FoolWhy Medtronic Stock Sank Today
There was plenty of action in the company's shares in the wake of its divisive fourth-quarter results.
- Zacks
Medtronic (MDT) to Expand Diabetes Care With New Buyout
Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.
Motley FoolMedtronic (MDT) Q4 2023 Earnings Call Transcript
Joining me are Geoff Martha, Medtronic chairman and chief executive officer; and Karen Parkhill, Medtronic chief financial officer. Geoff and Karen will provide comments on the results of our fourth quarter and fiscal year 2023, which ended on April 28, 2023, and our outlook for fiscal year '24.
ZacksMedtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.
Motley FoolWhy Medtronic Stock Is Sinking Today
Shares of the medical device maker Medtronic (NYSE: MDT) were down by 5% on heavy volume as of 10:53 a.m. ET Thursday. Although Medtronic topped Wall Street's consensus forecasts for the three-month period, investors appear to be reacting negatively to the company's financial guidance. Management blamed a stubbornly strong dollar and persistently high inflation for this softer-than-expected financial guidance.
Yahoo Finance VideoMedtronic stock drops amid earnings beat, forecast missing expectations
Yahoo Finance Live discusses a drop in shares of Medtronic after the medical device maker issued a weaker than expected forecast.
ZacksCompared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended April 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksMedtronic (MDT) Beats Q4 Earnings and Revenue Estimates
Medtronic (MDT) delivered earnings and revenue surprises of 0.64% and 3.59%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Medtronic to acquire wearable insulin patch maker EOFlow
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd. (KOSDAQ: 294090), manufacturer of the EOPatch® device — a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology™ algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more i
- Zacks
Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome
Medtronic (MDT) announces that the findings of the EV ICD Pivotal Study reinforce device safety and effectiveness.
Motley FoolMedtronic Stock: Bull vs. Bear
Medtronic (NYSE: MDT) is on a roll. Its shares have soared close to 15% year to date, easily outperforming the S&P 500. But is Medtronic a stock to consider buying right now? Here are the bull and bear cases for the medical device giant.
Motley FoolBetter Buy: Medtronic vs. Johnson & Johnson
Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) are perfect examples of this type of winning long-term investment. Medtronic sells devices worldwide related to diabetes, cardiovascular, neuroscience, and surgery. Thanks to its vast portfolio, Medtronic has increased earnings over time.
- PR Newswire
Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced longer-term follow-up results of its investigational EV ICD™ System, designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest. Findings from the Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Study, including patients followed through an average of 17.1 months, were presented as late-breaking science at Heart Rhythm 2023 in New Orleans. The EV ICD system is investi
PR NewswireMedtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring Solution
Medtronic plc (NYSE: MDT) today announced its AccuRhythm™ AI algorithm technology is the winner of the 7th annual MedTech Breakthrough Awards program as the "Best New Monitoring Solution." AccuRhythm AI is an artificial intelligence algorithm that improves the accuracy of heart rhythm event data from the Medtronic LINQ II™ insertable cardiac monitor (ICM) so physicians can better care for people with abnormal heart rhythms. The Medtronic AI technology was a standout from a field of nearly 4,000
ZacksMedtronic (MDT) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Medtronic (MDT) closed at $89.31, marking a +0.48% move from the previous day.
Motley FoolWhich Is the Safer Dividend Stock: Stryker or Medtronic?
Stryker (NYSE: SYK) and Medtronic (NYSE: MDT) are a pair of the biggest and most important medical-device and supply companies out there, but they're a bit different in the stability of the dividend income they offer to investors. Overall, Stryker's business is quite stable: It makes medical equipment, medical instruments, and surgical robotics for healthcare systems worldwide, and there isn't much in the way of rapidly shifting demand for its major segments. But it can reliably generate growth by investing in research and development (R&D) to make incremental improvements to its existing products, even if that growth is unlikely to be rapid due to the slow-growing nature of its markets. For example, developing more-advanced hip replacement products for use with its surgical robot system probably won't make investors rich overnight, but it'll keep the top and bottom lines expanding.
